Baxter International | Kortsiktig Gjeld



Current Liabilities Endring Dato
Abbott USD 14.16B 745M 2024-12
AtriCure USD 73.42M 1.01M 2024-12
Avanos Medical USD 165.9M 47M 2024-12
Baxter International USD 6.51B 311M 2024-12
Becton, Dickinson and Co. USD 7.66B 1.29B 2024-12
Boston Scientific USD 6.4B 489M 2024-12
Cooper Companies USD 999.6M 23.2M 2025-01
Dexcom USD 2.93B 1.2B 2024-12
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Fresenius EUR 6.09B 2.19B 2024-12
Globus Medical USD 855.91M 37.85M 2024-12
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
ICU Medical USD 556.18M 6.62M 2024-12
Insulet USD 528.4M 22.2M 2024-12
Integra LifeSciences USD 922.13M 9.56M 2024-12
Intuitive Surgical USD 2.21B 536.8M 2024-12
J&J USD 50.32B 1.44B 2024-12
Laboratory Of America USD 3.33B 81.8M 2024-12
Masimo USD 617.7M 19.9M 2024-12
Medtronic USD 11.84B 355M 2025-01
Merit Medical Systems USD 216.4M 15.32M 2024-12
Quest Diagnostics USD 2.17B 77M 2024-12
Smith & Nephew USD 1.53B 246M 2024-12
Stryker USD 7.62B 53M 2024-12
Tandem Diabetes Care USD 247.05M 12.23M 2024-12
Teleflex USD 649.36M 30.61M 2024-12
Terumo JPY 263.85B 32.8B 2024-12
Zimmer Biomet Holdings USD 2.45B 1.12B 2024-12



Baxter International Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.